ZNF418 and nasopharyngeal carcinoma: ZNF418, a DNA methylation regulator, is a transcriptional repressor, negatively affecting the MAPK signaling pathway, which plays an important role in NPC progression, chemotherapy resistance, and radiotherapy resistance (Zhang et al., 2019; Zheng et al., 2020).